Clear Street Group Inc.

Position in CNTN — Canton Strategic Holdings, Inc.

CIK 1881567 NEW YORK, NY

Position in CNTN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$2,132,834

-$2,932,829 QoQ

Shares Held

652,243

-61.0% QoQ

Ownership

0.934%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

of 41 holders

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Clear Street Group Inc. holds $24,636,408 across 4 Biotechnology names. CNTN ranks #3 (8.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APLS	Apellis Pharmaceuticals, Inc.	350,000	$14,080,500
2	SRPT	Sarepta Therapeutics, Inc.	361,391	$7,863,868
3	CNTN	Canton Strategic Holdings, Inc. This page	652,243	$2,132,834
4	MRNA	Moderna, Inc.	11,008	$559,206

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,132,834	652,243	-61.0%	Shares	Sole	2026-05-15
2025-12-31	$5,065,663	1,671,836	—	Shares	Sole	2026-02-13
No filing history on record for this holder in this stock.